Dr. Douglas Scharre started his career at The Ohio State University Medical Center in 1993 when he joined the Department of Neurology. He is a board certified neurologist, a clinical researcher and a master clinician regarding diagnosis and management of cognitive issues. His research focuses on early detection of Mild Cognitive Impairment (MCI) and dementia using cognitive evaluation and functional neuroimaging.
During Dr. Scharre’s tenure with OSU, he developed the SAGE Test, the self-administered cognitive assessment tool and the 4-Turn Test for assessment of driving abilities. He has conducted over 100 dementia related multi-center and investigator initiated clinical trials in the last 17 years that have been funded by the National Institute of Health (NIH), foundations, and industry. He has many active grants including clinical drug trials using cognitive enhancers and behavioral therapies, functional neuroimaging studies using SPECT and MRI, use of deep brain stimulation to improve symptoms in Alzheimer’s disease, and screening for mild cognitive impairment and early dementia diagnosis.
Dr. Scharre currently maintains repositories for brain tissue, cerebrospinal fluid and serum (brain and biomarker banks) on dementia subjects that researchers can utilize. He has also published multiple journal papers, book chapters, and abstracts on the topic of cognitive neurology. In fact, his recent book on Long-Term Management of Dementia is a stand-alone resource for health care professionals who diagnose, treat, and manage patients suffering from dementia.


![iStock_000005625298XSmall[1]_Workshops](http://ogg.osu.edu/wp-content/uploads/2012/05/iStock_000005625298XSmall1_Workshops.jpg)
![iStock_000002288249XSmall[1]_minority](http://ogg.osu.edu/wp-content/uploads/2012/05/iStock_000002288249XSmall1_minority.jpg)
![iStock_000003012769XSmall[1]_lightbulbs](http://ogg.osu.edu/wp-content/uploads/2012/05/iStock_000003012769XSmall1_lightbulbs.jpg)



